SCHEMBL20109181

SCHEMBL20109181

C=C(C(C)Cc1ccccc1)P1(=O)SCCS1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.41
HPGD P15428 1/20 0.41
CYP3A4 P08684 3/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 1/20 0.39
TAAR1 Q96RJ0 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TRPA1 O75762 2/20 0.38
SLC6A2 P23975 2/20 0.37
MAOA P21397 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109193 0.76 FAAH (0.43) HSD17B10HPGDCYP3A4MAPK1MAPT
SCHEMBL20109157 0.76 HSD17B10 (0.41) HSD17B10HPGDCYP3A4TSHRMAPK1
SCHEMBL20109132 0.72 HSD17B10 (0.45) HSD17B10HPGDCYP3A4TSHRMAPK1
SCHEMBL13622891 0.69 TAAR1 (0.50) HSD17B10HPGDCYP3A4TSHRMAPK1
SCHEMBL4824546 0.68 HPGD (0.57) HSD17B10HPGDCYP3A4TSHRMAPK1
SCHEMBL10161457 0.68 TAAR1 (0.54) HPGDCYP3A4TSHRMAPK1TAAR1
SCHEMBL22811040 0.68 TAAR1 (0.54) HPGDCYP3A4TSHRMAPK1TAAR1
SCHEMBL2625209 0.68 HPGD (0.56) HSD17B10HPGDCYP3A4TSHRMAPK1
SCHEMBL11724365 0.68 HPGD (0.56) HSD17B10HPGDCYP3A4TSHRMAPK1
SCHEMBL12880104 0.68 HPGD (0.56) HSD17B10HPGDCYP3A4TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 HSD17B10 4053/4885HPGD 504/4885CYP3A4 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.